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TThe  antiglobulin,  or  Coombs  test  is  part  of  the  compatibil-
ity  tests  that  any  patient  who  will  receive  a  red  blood  cell
transfusion  must  undergo.  This  test  is  also  essential  in  the
diagnostic  work  of  patients  with  anemia  whose  origin  is  not
easily  determined  and  when  the  etiology  must  be  identiﬁed
precisely.
In  1945,  Robin  Coombs,  Arthur  Mourant  and  Rob  Race
described  a  test  to  detect  anti-Rho  (anti-D)  non-agglutinant
antibodies.1 Originally,  the  test  was  devised  by  Robin
Coombs  as  part  of  his  postgraduate  studies  at  Race  and
Mourant’s  laboratory  in  Cambridge,  England  in  1945.  His  goal
was  to  study  the  characteristics  of  the  antibodies  involved
in  the  context  of  what  was  known  as  fetal  erythroblas-
tosis,  which  is  now  known  as  hemolytic  disease  of  the
newborn  (HDN),  caused  most  frequently  by  the  incompat-
ibility  between  an  Rh-negative  mother  sensitized  during  a
previous  pregnancy,  who  produces  IgG  anti-D  antibodies  able
to  pass  the  placenta  barrier  due  to  their  small  size  that  then
cover  the  fetal  red  blood  cells.  These  are  later  phagocytosed
in  the  spleen  and  liver,  organs  which,  in  addition  to  their
other  functions,  maintain  extramedullary  hematopoiesis  in
the  fetus  to  compensate  for  anemia  resulting  from  hemol-
ysis.  Later,  the  Coombs  test  was  used  to  demonstrate  the
presence  of  incomplete  antibodies  which  covered  the  eryth-
rocytes  in  vivo, such  as  is  seen  in  cases  of  autoimmune
hemolytic  anemia  (AHA).  The  description  of  the  method,
and  its  application  in  various  hematological  diseases,  was
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The  principles  of  the  antiglobulin  test  are  as  follows:
hen  immunoglobulins  of  the  IgG  class  (gamma  globulin)  and
he  complement  (beta  globulin)  of  human  origin  is  injected
nto  different  rabbits,  they  produce  IgG  antibodies  against
hese  globulins,  which  are  later  mixed  in  the  laboratory  to
roduce  the  broad  spectrum  Coombs  reagent,  which  is  used
n  daily  blood  banking  practice.  The  rabbit’s  IgG  antiglobulin
olecules  act  as  a  bridge,  which  unites  the  incomplete  IgG
ntibodies  covering  adjacent  red  blood  cells,  causing  agglu-
ination  and  visualization  of  the  reaction  to  the  naked  eye,
hich  can  be  seen  in  a  test  tube  or  gel  card,  interpreted  as
 positive  Coombs  test.
There  are  two  variants  of  this  test.  When  it  is  employed  to
etect  antibodies  bound  to  erythrocytes  in  vivo  it  is  known
s  a  direct  antiglobulin  test  or  direct  Coombs  test.  On  the
ther  hand,  when  the  antiglobulin  is  used  to  detect  the  pres-
nce  in  vitro  of  free  antibodies  in  serum  after  incubation
n  the  Coombs  phase  of  the  cross  match,  it  is  known  as  an
ndirect  antiglobulin  test,  or  an  indirect  Coombs  test.  This
ariant  of  the  test  is  the  one  that  is  used  in  the  detection
f  anti-D  antibodies  in  the  maternal  serum  of  women  who
re  D  antigen  negative,  as  well  as  the  search  for  and  identi-
cation  of  antibodies  in  serum  when  a  panel  of  commercial
rythrocytes,  whose  phenotype  is  known,  is  employed.3,4
pplications
he  direct  Coombs  testaona  C.  Rediscovering  the  Coombs  test.  Medicina  Univer-
.  In  the  investigation  of  antibodies,  such  as  those  in
patients  with  autoimmune  hemolytic  anemia.
.  In  the  investigation  of  alloantibodies,  such  as  in  newborns
suffering  hemolytic  disease  of  the  newborn.
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Interpretation of the anti-human globulin test
(Coombs test)
IndirectDirect
++ ––
There are
incomplete
antibodies
(IgG or C3d)
attached to
erythrocytes.
There are no
incomplete
antibodies
(IgG or C3d)
attached to 
erythrocytes.
There are no
incomplete
antibodies
(IgG or C3d)
present in the
patient’s
serum.
There are
incomplete
antibodies
(IgG or C3d) 
present in the 
patient’s
serum.
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.  To  document  a  hemolytic  transfusion  reaction.
he  indirect  Coombs  test
.  In  the  detection  of  irregular  antibodies  in  the  patient’s
serum.
.  In  the  determination  of  red  blood  cell  phenotypes.
.  As  part  of  the  crossmatch  test.
anual  and  automatic  methods  for  the  Coombs  test
hese  can  be  considered,  in  general:  (1)  test  tube  tech-
iques,  which  were  traditional  and  are  now  practically
nused,  (2)  microplate  techniques,  and  (3)  agglutination
echniques  in  gel  columns.  The  solid  phase  methods  (gel,
lass  beads  and  microplates)  appeared  in  the  90s  and  have
een  generalized  use  in  Mexico  since  the  year  2000.  Cur-
ently,  the  most-used  technique  is  that  of  cards  with  gel
olumns.
he Gel test
n  1990,  Lapierre  developed  a  system  of  gel  tests.5 These
ere  based  on  the  use  of  dextran  acrylamide  gel  particles,
 gel  matrix  which  acted  as  a  ﬁlter,  stopping  the  agglutinated
ed  blood  cells  from  passing  through  and  thus  trapping  red
lood  cells  on  the  surface  of  the  gel  according  to  their  size,
hich  constitutes  a  positive  test.  A  negative  reaction  forms
 button  of  non-agglutinated  red  blood  cells  at  the  bottom
f  the  microtube.  The  gel  card  contains  6  microtubes,  which
llows  for  the  determination  of  6  different  antigens  and  anti-
odies,  usually  ABO  blood  type  (direct  and  inverse)  and  Rh
D-antigen),  compatibility  tests,  and  Coombs  tests.  These
ests  can  be  carried  out  manually  or  automatically.5
Among  the  advantages  of  automation  are  the  following:
 larger  number  of  samples  can  be  analyzed,  washed  eryth-
ocytes  are  not  required,  precision  and  reproducibility  are
mproved,  subjectivity  in  the  interpretation  of  the  results
s  eliminated,  the  results  can  be  preserved  for  hours,  and
anual  labor  is  reduced,  minimizing  susceptibility  to  error
n  the  different  phases  of  the  test.
he  direct  Coombs  test
hen  the  direct  antiglobulin  test  is  positive,  this  means  that
ncomplete  IgG  antibodies  or  fragments  of  the  complement
speciﬁcally  C3d),  are  present,  on  the  erythrocytes.  On  the
ther  hand,  when  there  is  no  agglutination  (a  negative  test),
hese  antibodies  are  not  present  on  the  erythrocytes’  sur-
ace  (Fig.  1).6
A  negative  direct  Coombs  test  does  not  necessarily
ean  that  there  are  no  incomplete  antibodies  on  the  red
lood  cells,  since  the  usual  reagents  for  human  polyspeciﬁc
ntiglobulins,  which  are  used  daily  in  blood  banks,  only  react
hen  there  are  at  least  200  IgG  molecules  or  more  per  eryth-Please  cite  this  article  in  press  as:  Jaime-Pérez  JC,  Almaguer-G
sitaria.  2016.  http://dx.doi.org/10.1016/j.rmu.2016.07.001
ocyte.  In  the  same  manner,  if  the  antibody  involved  is  an
gA,  as  in  some  cases  of  autoimmune  hemolytic  anemia,  the
est  will  be  negative,  since  the  standard  Coombs  reagent
oes  not  contain  anti-IgA  antibodies.7,8igure  1  Interpretation  of  the  results  of  the  anti-human  glob-
lin or  Coombs  tests.
he  indirect  Coombs  test
he  indirect  human  antiglobulin  test  is  positive  when  there
re  free  IgG  antibodies  in  the  serum,  as  is  the  case  with
emolytic  disease  of  the  newborn,  the  test  is  also  routinely
sed  for  identiﬁcation  of  irregular  (unexpected)  antibodies
mploying  a  commercial  panel  of  red  blood  cells  (Fig.  1).6
In  conclusion,  since  its  introduction  to  the  clinical  labora-
ory  70  years  ago,  the  Coombs  test  has  evolved  technically,
nd  its  principles  continue  to  be  applicable  today,  which
akes  this  simple  and  economic  test  one  of  the  most  ver-
atile  and  important  used  in  the  diagnosis  of  hematological
iseases,  and  in  the  safe  practice  of  transfusion  medicine.
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